Project Delays Hurt etrials in First Quarter

Monday, May 12, 2008 11:32 AM

Morrisville, N.C.-based eClinical company etrials reported another challenging quarter with a drop in net service revenue of $3.7 million for the first quarter of 2008 compared to $4.1 million reported in 2007. Quarter over quarter, the company’s profit losses widen with a $2.0 million net loss for the quarter (or $0.19 per share) compared with a loss of $900,000 during the first quarter of 2007. etrials stated that its drop in revenue was partly due to new project delays, resulting in about $1 million in lost revenue.

"Despite the delayed project starts…we continue to increase studies with existing clients and add new clients. Our qualified pipeline is up nearly 50%; our close rates nearly doubled over last year; and we closed a number of multi-product solution sales with both new and existing clients. The sales metrics we follow are improving and we are where we planned to be at this stage of our sales re-engineering efforts," said etrials chief executive officer, Chip Jennings.

New product bookings for the first were also slightly down compared to the first quarter of 2007, with reportings of $4.8 million and $6.6 million respectively. And etrials booked $7 million during the last quarter of 2007. On a positive note, the company stated it held $20.3 million in backlogged business compared with $19.8 million on March 31, 2007 and $19.2 million on December 31, 2007. The company stated this reflected a trend towards fewer project cancellations and delays.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs